Zoetis profit beats Street on strong pet product sales

April 30 (Reuters) - Zoetis Inc, formerly the animal health subsidiary of U.S. pharmaceuticals giant Pfizer Inc , posted a better-than-expected quarterly profit, driven by strong growth in sales of pet products in the United States.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.